Deva Holding AS 2025 AR2
The report outlines DEVA Holding's operational, financial, and sustainability performance for the fiscal year 2025. Despite global economic challenges, the company expanded its product portfolio by launching 35 new products across 10 therapeutic areas and reached 1,863 marketing authorizations in 86 countries. DEVA Holding published its first comprehensive sustainability report aligned with national regulatory frameworks and established a Sustainability Subcommittee to oversee its ESG strategy. Additionally, the company maintained its focus on R&D through its center DEVARGE, filing 14 patent applications and publishing 15 scientific articles.
Company: Deva Holding AS
Sector: Health Care
Country: Turkiye
Year: 2025
Type: AR2
Pages: 45
Deva Holding AS
Annual Report
The report outlines DEVA Holding's operational, financial, and sustainability performance for the fiscal year 2025. Despite global economic challenges, the company expanded its product portfolio by launching 35 new products across 10 therapeutic areas and reached 1,863 marketing authorizations in 86 countries. DEVA Holding published its first comprehensive sustainability report aligned with national regulatory frameworks and established a Sustainability Subcommittee to oversee its ESG strategy. Additionally, the company maintained its focus on R&D through its center DEVARGE, filing 14 patent applications and publishing 15 scientific articles.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board